Malcolm Peet

Summary

Publications

  1. ncbi request reprint A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms
    Malcolm Peet
    Swallownest Court, Aughton Road, S26 4TH, Sheffield, UK
    J Psychiatr Res 36:7-18. 2002
  2. ncbi request reprint Omega-3 fatty acids in the treatment of psychiatric disorders
    Malcolm Peet
    Swallownest Court Hospital, Doncaster and South Humber Healthcare NHS Trust, Sheffield, UK
    Drugs 65:1051-9. 2005
  3. ncbi request reprint Dietary sugar and polyunsaturated fatty acid consumption as predictors of severity of schizophrenia symptoms
    Caroline Stokes
    Rotherham Mental Health Services, Swallownest Court, Sheffield, S26 4TH, UK
    Nutr Neurosci 7:247-9. 2004
  4. ncbi request reprint Nutrition and schizophrenia
    Malcolm Peet
    Doncaster and South Humber NHS Trust, Sheffield, UK
    World Rev Nutr Diet 95:17-28. 2005
  5. ncbi request reprint Omega-3 polyunsaturated fatty acids in the treatment of schizophrenia
    Malcolm Peet
    Swallownest Court Hospital, Sheffield, Great Britain
    Isr J Psychiatry Relat Sci 45:19-25. 2008
  6. ncbi request reprint The metabolic syndrome, omega-3 fatty acids and inflammatory processes in relation to schizophrenia
    Malcolm Peet
    Doncaster and South Humber Healthcare NHS Trust, Rotherham Services, Early Intervention Service, Swallownest, Sheffield, S26 4TH, UK
    Prostaglandins Leukot Essent Fatty Acids 75:323-7. 2006
  7. ncbi request reprint Polyunsaturated fatty acid levels in red cell membranes of unmedicated schizophrenic patients
    Malcolm Peet
    Rotherham Mental Health Services, Swallownest Court, Aughton Road, Sheffield, S26 4TH, UK
    World J Biol Psychiatry 5:92-9. 2004
  8. ncbi request reprint International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysis
    Malcolm Peet
    Swallownest Court Hospital, Aughton Road, Sheffield S26 4TH, UK
    Br J Psychiatry 184:404-8. 2004
  9. ncbi request reprint Nutrition and schizophrenia: beyond omega-3 fatty acids
    Malcolm Peet
    Swallownest Court Hospital, Aughton Road, Sheffield S26 4TH, UK
    Prostaglandins Leukot Essent Fatty Acids 70:417-22. 2004
  10. ncbi request reprint Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results
    Malcolm Peet
    Swallownest Court Hospital, Aughton Road, Sheffield S26 4TH, UK
    Prostaglandins Leukot Essent Fatty Acids 69:477-85. 2003

Collaborators

Detail Information

Publications15

  1. ncbi request reprint A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms
    Malcolm Peet
    Swallownest Court, Aughton Road, S26 4TH, Sheffield, UK
    J Psychiatr Res 36:7-18. 2002
    ..This effect was greatest at 2 g/day. There was a positive relationship between improvement on rating scales and rise in red blood cell arachidonic acid concentration...
  2. ncbi request reprint Omega-3 fatty acids in the treatment of psychiatric disorders
    Malcolm Peet
    Swallownest Court Hospital, Doncaster and South Humber Healthcare NHS Trust, Sheffield, UK
    Drugs 65:1051-9. 2005
    ..However, as the clinical research evidence is preliminary, large, and definitive randomised controlled trials similar to those required for the licensing of any new pharmacological treatment are needed...
  3. ncbi request reprint Dietary sugar and polyunsaturated fatty acid consumption as predictors of severity of schizophrenia symptoms
    Caroline Stokes
    Rotherham Mental Health Services, Swallownest Court, Sheffield, S26 4TH, UK
    Nutr Neurosci 7:247-9. 2004
    ..54, p = 0.02) and this was independent of the effect of medication. This finding is consistent with earlier studies...
  4. ncbi request reprint Nutrition and schizophrenia
    Malcolm Peet
    Doncaster and South Humber NHS Trust, Sheffield, UK
    World Rev Nutr Diet 95:17-28. 2005
  5. ncbi request reprint Omega-3 polyunsaturated fatty acids in the treatment of schizophrenia
    Malcolm Peet
    Swallownest Court Hospital, Sheffield, Great Britain
    Isr J Psychiatry Relat Sci 45:19-25. 2008
    ..However, such approaches have been little evaluated in mental health....
  6. ncbi request reprint The metabolic syndrome, omega-3 fatty acids and inflammatory processes in relation to schizophrenia
    Malcolm Peet
    Doncaster and South Humber Healthcare NHS Trust, Rotherham Services, Early Intervention Service, Swallownest, Sheffield, S26 4TH, UK
    Prostaglandins Leukot Essent Fatty Acids 75:323-7. 2006
    ..The associations may derive either from genetic or from environmental factors, including nutrition. Further investigation of these associations may give important clues regarding the aetiology of schizophrenia...
  7. ncbi request reprint Polyunsaturated fatty acid levels in red cell membranes of unmedicated schizophrenic patients
    Malcolm Peet
    Rotherham Mental Health Services, Swallownest Court, Aughton Road, Sheffield, S26 4TH, UK
    World J Biol Psychiatry 5:92-9. 2004
    ....
  8. ncbi request reprint International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysis
    Malcolm Peet
    Swallownest Court Hospital, Aughton Road, Sheffield S26 4TH, UK
    Br J Psychiatry 184:404-8. 2004
    ..Dietary variations are known to predict the prevalence of physical illnesses such as diabetes and heart disease but the possible influence of diet on mental health has been neglected...
  9. ncbi request reprint Nutrition and schizophrenia: beyond omega-3 fatty acids
    Malcolm Peet
    Swallownest Court Hospital, Aughton Road, Sheffield S26 4TH, UK
    Prostaglandins Leukot Essent Fatty Acids 70:417-22. 2004
    ....
  10. ncbi request reprint Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results
    Malcolm Peet
    Swallownest Court Hospital, Aughton Road, Sheffield S26 4TH, UK
    Prostaglandins Leukot Essent Fatty Acids 69:477-85. 2003
    ....
  11. ncbi request reprint A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs
    Malcolm Peet
    Swallownest Court Hospital, Sheffield, England
    Arch Gen Psychiatry 59:913-9. 2002
    ..In depressed patients, low blood levels of eicosapentaenoic acid are seen. We tested the antidepressive effect of ethyl-eicosapentaenoate in these patients...
  12. ncbi request reprint Diet, diabetes and schizophrenia: review and hypothesis
    Malcolm Peet
    Swallownest Court Hospital, Aughton Road, Sheffield S26 4TH, UK
    Br J Psychiatry Suppl 47:S102-5. 2004
    ..Diabetes is more common in people with schizophrenia than in the general population...
  13. ncbi request reprint Nutrition and schizophrenia: an epidemiological and clinical perspective
    Malcolm Peet
    Nutr Health 17:211-9. 2003
    ..These findings suggest a new paradigm for our understanding of the causation and treatment of schizophrenia...
  14. ncbi request reprint Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry
    Marlene P Freeman
    Women s Mental Health Program, Department of Psychiatry, University of Arizona College of Medicine, Tucson 85724 5002, USA
    J Clin Psychiatry 67:1954-67. 2006
    ..To determine if the available data support the use of omega-3 essential fatty acids (EFA) for clinical use in the prevention and/or treatment of psychiatric disorders...
  15. doi request reprint Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder
    Shima Jazayeri
    Department of Nutrition and Biochemistry, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
    Aust N Z J Psychiatry 42:192-8. 2008
    ..To compare therapeutic effects of eicosapentaenoic acid (EPA), fluoxetine and a combination of them in major depression...